Posaconazole Therapeutic Drug Monitoring: a Reference Laboratory Experience-Reference-Cited by-同舟云学术

Posaconazole Therapeutic Drug Monitoring: a Reference Laboratory Experience

Published:2009-05 Issue:5 Volume:53 Page:2223-2224
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Thompson George R.¹,Rinaldi Michael G.²,Pennick Gennethel²,Dorsey Sheryl A.²,Patterson Thomas F.³,Lewis James S.⁴

Affiliation:

1. Division of Infectious Diseases  Department of Medicine  University of Texas Health Science Center at San Antonio  San Antonio, Texas 78229

2. Fungus Testing Laboratory  Department of Pathology  The University of Texas Health Science Center at San Antonio  San Antonio, Texas 78229

3. South Texas Veterans Health Care System  San Antonio, Texas 78245

4. Department of Pharmacy  University Health System  San Antonio, Texas 78229

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.00240-09

Reference9 articles.

1. Antifungal Therapeutic Drug Monitoring: Established and Emerging Indications

2. Cornely, O. A., J. Maertens, D. J. Winston, J. Perfect, A. J. Ullmann, T. J. Walsh, D. Helfgott, J. Holowiecki, D. Stockelberg, Y. T. Goh, M. Petrini, C. Hardalo, R. Suresh, and D. Angulo-Gonzalez. 2007. Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.N. Engl. J. Med.356:348-359.

3. FDA. Accessed 17 February 2009. Posaconazole. FDA briefing document. http://www.fda.gov/cder/foi/nda/2006/022003s000_NoxafilTOC.htm .

4. Pharmacokinetics and Safety of Oral Posaconazole in Neutropenic Stem Cell Transplant Recipients

5. Krishna, G., M. Martinho, P. Chandrasekar, A. J. Ullmann, and H. Patino. 2007. Pharmacokinetics of oral posaconazole in allogeneic hematopoietic stem cell transplant recipients with graft-versus-host disease. Pharmacotherapy27:1627-1636.

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MSG-15: Super-Bioavailability Itraconazole Versus Conventional Itraconazole in the Treatment of Endemic Mycoses—A Multicenter, Open-Label, Randomized Comparative Trial;Open Forum Infectious Diseases;2024-01-29

2. Progress of triazole antifungal agent posaconazole in individualized therapy;Journal of Clinical Pharmacy and Therapeutics;2022-12

3. Real‐world effectiveness of antifungal prophylaxis with posaconazole as the primary agent in patients with haematological malignancies;Mycoses;2022-07-25

4. Azole Therapeutic Drug Monitoring and its Use in the Management of Invasive Fungal Disease;Current Fungal Infection Reports;2022-03-11

5. Population pharmacokinetics of a posaconazole tablet formulation in transplant adult allogeneic stem cell recipients;European Journal of Pharmaceutical Sciences;2022-01